Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates
WEDNESDAY, Dec. 22, 2021 (HealthDay News) — Mandatory COVID-19 certification may increase vaccine uptake, but the results may vary according to country-specific conditions, according to a study published online Dec. 13 in The Lancet Public Health.
Melinda C. Mills, Ph.D., and Tobias Rüttenauer, both from the University of Oxford in the United Kingdom, investigated the effect of mandatory COVID-19 certification on vaccine uptake. The model compared six countries (Denmark, Israel, Italy, France, Germany, and Switzerland) that introduced certification (April to August 2021) to 19 control countries. COVID-19 certification meant showing vaccination, a recent negative test, or proof of recovery.
The researchers found that COVID-19 certification led to increased vaccinations 20 days before implementation in anticipation, with a lasting effect up to 40 days after. This increase was more pronounced in countries with preintervention uptake that was below average (e.g., France) compared with those where uptake was already average or higher. There was no effect in countries that already had average uptake (e.g., Germany), and there was an unclear effect when certificates were introduced during a period of limited vaccine supply (e.g., Denmark).
“Mandatory COVID-19 certification could increase vaccine uptake, but interpretation and transferability of findings need to be considered in the context of preexisting levels of vaccine uptake and hesitancy, eligibility changes, and the pandemic trajectory,” the authors write.
Financial Incentives Boost Tobacco Abstinence in Underserved Adults
Gap Found Between Awareness of Breast Cancer Risk and Risk-Reducing Behavior
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
Trends Reported in Vaccination Coverage for Adolescents for 2025